• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Encore Life, LLC and WholeScripts, LLC Announce Partnership Agreement

Share:

January 27, 2020

Encore Life, the only practitioner-exclusive professional grade CBD manufacturer, and WholeScripts, powered by XYMOGEN, the fastest growing supplier of nutritional supplements, have signed a partnership agreement naming Encore Life as the premier CBD product line offered via WholeScripts’ sales channels. This partnership grants the companies’ valued practitioner partners easier access to quality CBD through one single online platform, streamlining the order process and meeting increasing patient demand. The initial product release will include Encore Life’s Broad-Spectrum PRO series oils, available in 750 mg, 1500 mg, and 3000 mg concentrations.

“We’re thrilled to have WholeScripts offer our professional grade CBD products as our trusted partner. WholeScripts powered by XYMOGEN, is known for their top-quality nutritional supplements, and this partnership grants the practitioner and their patients complete confidence in the quality of their CBD product purchase,” said Sean DeWitt, CEO of Encore Life. “Encore Life is committed to only offering its innovative products through practitioners, exclusively, and given WholeScripts’ shared vision it was an easy decision for our company.”

“Encore Life, a premier brand of CBD, was heavily requested by our physicians and representatives,” said Mike Mahoney, Senior Vice President of WholeScripts. “Our team is extremely excited to be offering Encore CBD as one of our first brand partners at WholeScripts. Encore’s support of the practitioner market, quality and purity makes them a great fit to continue our mission for a unique and secure practitioner relationship.”

Source: BioSpace

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Australian Medtech Startup Nutromics Bags $4M in Pre-Market Funding for Continuous Molecular Monitoring DeviceAustralian Medtech Startup Nutromics Bags $4M in Pre-Market Funding for Continuous Molecular Monitoring Device
  • Acasti Pharma Inc. Centralizes Marketplace For Shares On The Nasdaq With Voluntary Delisting from TSX Venture ExchangeAcasti Pharma Inc. Centralizes Marketplace For Shares On The Nasdaq With Voluntary Delisting from TSX Venture Exchange
  • 30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired By Convatec Group Plc for Several Applications30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired By Convatec Group Plc for Several Applications
  • Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.
  • How COVID-19 Made Employee Safety Work for EmployeesHow COVID-19 Made Employee Safety Work for Employees
  • 4 Areas Driving AI Adoption in Hospital Operations and Patient Safety4 Areas Driving AI Adoption in Hospital Operations and Patient Safety
  • RealSelf Acquires Tajmeeli.com to serve Arabic-Speaking Medical Aesthetics MarketRealSelf Acquires Tajmeeli.com to serve Arabic-Speaking Medical Aesthetics Market
  • Life Science Sales Strategies – Know the Nuances of Your CustomerLife Science Sales Strategies – Know the Nuances of Your Customer

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications